
    
      Patients enrolled received a device with cardiac resynchronization therapy (CRT) and
      defibrillation. Patients were randomized to CRT on or off for up to six months and evaluated
      for mortality, hospitalization, and functional outcomes including exercise capacity, quality
      of life, symptomatic status, and echocardiographic analysis.
    
  